ABCL Stock: Price, Earnings History and SEC Filings
AbCellera Biologics Inc. (ABCL) last traded at $12.27, down 6.19% on the latest session and down 15.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.18 against an analyst estimate of $-0.17, a miss of 5.9%.
$12.27 -6.19%
1 month-15.90%
52-week high$15.02
52-week low$2.75
Volume3.88M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ABCL earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $-0.18 | $-0.17 | -5.88% |
| Mar 2026 | May 11, 2026 | $-0.14 | $-0.22 | +36.36% |
| Dec 2025 | Feb 24, 2026 | $-0.03 | $-0.18 | +83.33% |
| Sep 2025 | Nov 6, 2025 | $-0.19 | $-0.17 | -11.76% |
ABCL beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ABCL
SEC filing data is not available right now. You can search for ABCL on SEC EDGAR.
ABCL news
- AbCellera to Present at Upcoming Investor Conferences in November 2026Oct 22, 2026 · finance.yahoo.com
About AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) is a US-listed public company on Nasdaq.